
AI Agents Are Coming To Healthcare
A digital workforce is coming to healthcare.
getty
Y Combinator calls 2025 the 'year of AI agents,' and singled out healthcare as a key focus area. Bill Gates predicts that agents will 'upend the software industry, bringing about the biggest revolution in computing since we went from typing commands to tapping on icons." Nvidia CEO Jensen Huang recently proclaimed that agents "present a trillion-dollar opportunity.'
You get the point. Agents are all the rage throughout the tech industry. But what exactly are agents? What role might they play in healthcare? And what's holding them back from realizing their potential?
Because early chatbots used decision trees and scripted responses, they struggled with in-depth conversations. With ChatGPT's release, millions of people discovered how to interact with large language models across an almost unlimited range of topics.
Agents build on that foundation. They are LLMs enhanced with capabilities such as retrieval, memory, and tools—enabling them to carry out narrowly defined tasks without human supervision (e.g., booking a flight or responding to a customer service request). While copilots assist humans, agents take over tasks entirely. Agentic AI coordinates multiple task-specific agents to accomplish multi-step goals.
Many healthcare provider organizations are struggling. Their workforces are strained and shorthanded. Margins are thin, labor costs are rising, and many processes are inefficient and wasteful. Meanwhile, patients often struggle to access timely, affordable, and effective care.
Numerous industries, such as banking, travel, and personal finance, have improved productivity and service by doing more with fewer people. Agents may unlock similar opportunities in healthcare. Always on, scalable, and tireless, agents could automate a range of administrative and even clinical processes.
That's why many view agents not just as tech, but as operational infrastructure and digital labor. As Luminai CEO Kesava Kirupa Dinakaran explained, 'When you think about how computers can drive value, it's by improving operations. At their core, healthcare organizations are all about operations.' The hope is that agents can expand access, lower costs, improve experiences, and enhance outcomes.
A burgeoning wave of companies is racing to deliver AI agents that enable provider organizations to do more with less.
Call centers are today's leading use case. Most patients still make appointments by phone, and many skip them due to scheduling hassles. Agents can manage inbound calls by conversing with patients and taking the next best actions (e.g., scheduling an appointment or making a referral). When agents cannot handle an end-to-end call, they can verify key details, summarize the conversations, and hand off to human staff.
Assort Health Co-CEO Jeff Liu explained that his company aims to help healthcare organizations 'train the best operators they ever had.' By turning scheduling protocols into rules engines and plugging agents into EHRs, his co-CEO Jon Wang reported that their company automates most inbound calls—routing the rest to call center workers and nurses in priority order.
Similarly, Hello Patient CEO Alex Cohen reports that his company's 'fully generative voice and SMS agents handle real-time front‑office calls and proactively re-engage patients, letting clinics boost access and fill schedules without adding headcount.'
Agents are also handling outbound calls. Notable's agents prepare patients for clinic visits by verifying their insurance benefits, clarifying (and documenting) their reason for the visit, and checking them in for their appointments. Qventus' agents help optimize patients for procedures and surgeries by providing preparation instructions, sending appointment reminders, answering general care questions, and coordinating pre-admission testing. Infinitus deploys agents to perform health risk assessments and help patients access specialty therapies and rare disease programs.
Some agents support patients between and after visits. Ambience Healthcare is developing agents that send follow-up instructions, medication reminders, and scheduling prompts based on visit notes. Hippocratic AI provides a constellation of agents for nurse-level clinical tasks, such as making post-discharge follow-up calls and closing care gaps. The company calls this 'super staffing' since many organizations lack the staff to do enough of this work on their own. Sword Health, a digital physical therapy platform, uses agents to onboard patients, provide customer service, and even help them return hardware. And Cedar recently launched an AI voice agent, Kora, to handle billing inquiries, explain charges, surface payment options, and connect patients with financial assistance.
Agents are not limited to patient-facing roles—they're also streamlining the back office. For example, one of Luminai's agents reads incoming faxes and automatically triggers downstream workflows like refills and referrals. VoiceCare AI automates communication between provider organizations, insurers, and patients. Its CEO, Parag Jhaveri, reported that their agent, Joy, can wait on hold for more than 30 minutes, navigate phone trees, sustain multi-hour conversations, and take actions like updating claims and filing requests.
Building a well-scripted, polished demo is easy. Delivering reliable performance on real-world healthcare tasks is much harder. Agents often score far short of human performance. For one, healthcare is complex—filled with edge cases, exceptions, and contextual nuance. As legendary software engineer Steven Sinofsky noted, automation is ultimately about handling exceptions, not the routine.
Several technical barriers stand in the way. Healthcare data is deeply siloed and fragmented. Lisa Bari, Head of External Affairs at Innovaccer, warns against deploying agents without full contextual data.
Also, while LLMs enable agents to handle a wide range of inputs, they can produce uncontrolled outputs. Longer conversations and more contextual data can reduce accuracy and increase latency. Moreover, error rates compound across multi-step processes. For example, an agent with 98% per step will complete a five-step task successfully only 90% of the time (0.98⁵).
Developers use various strategies to make agents more reliable. As Sword Health product lead Rik Renard, RN, emphasized, "Evaluating agents' output against pre-specified criteria is essential for deploying reliable agents, yet few people discuss this.'
Many agentic systems use specialized knowledge graphs to contextualize information and 'coordinating agents' to link multiple, narrow task-specific agents. Technical guardrails help ensure agents stay within scope and flag questionable output for human review.
Still, picking the right use cases is critical. Notable Chief Medical Officer Dr. Aaron Neinstein told me that his company first deploys agents in low-risk areas (e.g., patient intake) to build trust before expanding into more complex workflows.
Even with clear use cases, deployment remains hard and no shortcuts exist. As Cedar CEO Dr. Florian Otto summed it up, 'Agents must be built workflow by workflow and only deployed when they reliably work well.'
Agents must also integrate with other tech systems—like EHRs and CRMs—to access contextual data and execute tasks. Most use native API integrations, though some interact through the same point-and-click interfaces that healthcare workers use.
Ultimately, in an 'agentic economy,' agents must interact with one another—communicating information, transferring resources, collaborating, and tracking transactions. This will require persistent identity and seamless communication protocols, which developers are now building. Several companies, including Salesforce, Microsoft, and Innovaccer, have launched platforms to orchestrate multi-agent healthcare workflows.
"Any sufficiently advanced technology is indistinguishable from magic.'
Arthur C. Clark famously explained, "Any sufficiently advanced technology is indistinguishable from magic.' If you haven't interacted with an AI agent or tried a modern voice model, you should. This isn't your mother's old pharmacy's IVR system. The technology has crossed the uncanny valley — it feels like magic.
But unlike magic, it's not infallible. In high-stakes situations, unreliable AI can cause real harm. As extreme examples, consider how the National Eating Disorder Association's chatbot 'Tessa' encouraged users with eating disorders to diet, or how a Character.AI companion allegedly pushed a teenager to commit suicide.
Agents, however, are more than chatbots. They are tireless digital workers who are always ready to complete specific tasks. When stitched together, they can form multi-agent systems—or 'agent swarms'— that handle complex, interdependent processes and behaviors.
Yet, US and EU regulators have approved exceedingly few healthcare AI agents. Hardian Health's Dr. Hugh Harvey warns, "Health systems and clinicians using unregulated AI agents must accept all the risk.' Will they be willing? While regulatory approval is cumbersome, it may be necessary to speed adoption.
Also, unlike magic, AI agents aren't plug-and-play. Implementing agents is a massive change-management undertaking.
Patients will need to adjust their expectations and learn to interact differently with technology and healthcare. In his book Alchemy, Rory Sutherland explains that in our 'unrelenting quest' for greater efficiency, we often forget to ask 'whether people like efficiency as much as economic theory believes they do.'
Take the 'doorman fallacy:' a hotel that replaces doormen with automatic doors may save money, while overlooking the other valuable functions doormen provide, such as hailing taxis, providing security, welcoming guests, and signaling the hotel's status.
Similarly, healthcare workers often do far more than their simple job description. For example, if agents automate scheduling, who will reassuringly mention that 'everyone loves Dr. Smith' or that she tends to run late at the end of the day?
Of course, healthcare workers aren't perfect or always available. Several company leaders I spoke with say patients prefer interacting with their agents over healthcare workers. But this remains to be seen. Outside healthcare, Klarna—the buy now, pay later company—recently walked back its ambitious efforts to replace two-thirds of its customer service workforce with AI agents. It turns out many customers still want to talk to real people.
Agents will also reshape how healthcare workers do their jobs. By offloading drudgery, agents could empower some. Yet others may resent having to babysit new digital coworkers that could potentially replace them.
Interestingly, one company CEO shared that executives and managers–not frontline staff–are often the most resistant. Perhaps they worry agents will shrink their teams and reduce their influence. Or, more likely, they may feel daunted by all that responsible deployment demands: surfacing tacit knowledge, defining ground truths, streamlining workflows, and retraining workers for new forms of human-AI collaboration.
Infinitus CEO Ankit Jain explained his company 'sells outcomes, not technology.' It focuses on supporting change management, recognizing that 'organizations must be able to crawl before they walk and then run.'
For agents to succeed, organizations must look inward. Technology is an amplifier. It can boost productivity or magnify inefficiency. Healthcare organizations, which strongly pull towards inertia, must actively reexamine their operations, rebalance their workforces, and reinforce their digital governance. Otherwise, poorly integrated agents could cause confusion and chaos.
Optimizing workflows is essential. So is relieving downstream constraints. For example, a flawless appointment-scheduling agent is of limited value if doctors' schedules are always full. An outreach agent that flags patient needs is only helpful if there are enough nurses and clinicians available to respond.
Taken together, these developments point toward a future that's both promising and uncertain.
'Technology is neither good nor bad; nor is it neutral.'
Healthcare's digital history has taught us hard lessons: technology can help, but it cannot miraculously solve all problems. And tech doesn't work in isolation—lasting change depends on rethinking people, processes, and priorities, not just deploying tools.
Roy Amara famously observed, 'We tend to overestimate the effect of a technology in the short run and underestimate the effect in the long run.' That seems likely with AI agents.
In the near term, agents will make existing workflows faster and cheaper—answering calls, managing intake, and making appointments. Next, they may improve those workflows—coordinating across channels, adding personalization, and responding with context. Eventually, they may enable entirely new approaches, with networks of agents operating semi-autonomously across systems.
At the heart of this evolution is a core tension: leverage versus certainty. Agents promise a kind of abundance—tireless labor at negligible cost. But that leverage introduces risk. For now, they'll likely remain in administrative domains, where errors are less costly and rarely dangerous.
Still, care delivery is also quite inefficient. Care models for both acute and chronic illness have barely changed in decades—and the clinician-patient encounter remains healthcare's choke point.
Here, too, agents may help: handling triage, guiding protocol-driven decisions, even managing chronic conditions. Much of this is already technically feasible. But real progress will require much more: rigorous evaluation, regulatory clarity, updated business models, cultural acceptance, redesigned teams, and seamless escalation paths to human care.
Melvin Kranzberg's First Law reminds us: 'Technology is neither good nor bad; nor is it neutral.' The promise of agents is real—but conditional. Their impact depends on how we design, deploy, and govern them.
Will agents make care more personalized—or more transactional? Will they return time to clinicians—or reduce their autonomy and turn them into machine supervisors? Will they bring people closer together—or insert more distance? Will they relieve burden—or hollow out the human core of care?
Agents are coming. What they become depends on us.
I thank the following people for discussing this topic with me: Ray Chen and Jonathan Fullerton (Ambience Healthcare), Jeffery Liu and Jon Wang (Assort Health), Florian Otto (Cedar), Hugh Harvey (Hardian Health), Alex Cohen (HelloPatient), Rick Keating (Hippocratic AI), Ankit Jain (Infinitus), Abhinav Shashank and Lisa Bari (Innovaccer), Pankaj Gore (Insight Health), Kesava Kirupa Dinakaran (Luminai), Aaron Neinstein and Tushar Garg (Notable), David Atashroo (Qventus), Rouhaan Shahpurwala (Sully.AI), Rik Renard and Kevin Wong (Sword Health), Maria Gonzalez Manso (Tucuvi), Parag Jhaveri (VoiceCare AI), Sergei Polevikov (WellAI), and Stuart Winter-Tear.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Wall Street Journal
36 minutes ago
- Wall Street Journal
Voyager Technologies Rises in Debut, Signaling Improving IPO Market
Shares of space and defense technology company Voyager Technologies surged in their New York Stock Exchange debut Wednesday, another sign of an improving market for initial public offerings. The stock ended the regular session at $56.48 and was up 6% after hours to $60.15.


Axios
36 minutes ago
- Axios
Nvidia CEO Jensen Huang is getting quantum computing fever
Jensen Huang's doubts about quantum computing's potential — or at least the speed with which it'll develop — appear to be fading. Why it matters: The Nvidia CEO's perspectives on any technologies touching the AI economy are market moving and narrative shaping. Driving the news: Huang told VivaTech 2025 in Paris Wednesday that quantum computing is raring to go — something of a reversal from the outright skepticism he expressed earlier this year. "Today I can tell you there's an inflection point happening," Huang said. "It is clear now we are within reach of being able to apply quantum computing — quantum classical computing — in areas that can solve some interesting problems in the coming years," he added. "This is a really exciting time." Context: Nvidia products and technologies are used in quantum development. And Huang announced Wednesday that the company's quantum algorithm stack will be paired with its Grace Blackwell 200 chip to accelerate quantum efforts. The impact: His remarks delivered a burst of investor interest in quantum stocks. Quantum Computing Inc shares soared 25% Wednesday, while Rigetti Computing closed up 11%. How it works: Classical computers, even the most powerful supercomputers, do their calculations through the binary manipulation of bits, which can be in only two states: on or off, 1 or 0. Quantum computers use the quantum state of an object to produce what's known as qubits. The complex math behind these qubits can be plugged into special algorithms to do calculations that would be impossible for a classical computer to perform. This could have huge implications for everything from drug discovery, to financial modeling, to AI development.
Yahoo
38 minutes ago
- Yahoo
Fund manager who sold Tesla, just in time, says investors are overlooking these tech bargains
Two weeks ago, Wall Street veteran Gary Black sold his remaining Tesla shares, helping clients sidestep a selloff driven by a public fallout between Chief Executive Elon Musk and President Donald Trump. Black's unease with Tesla TSLA goes back a ways. When the managing partner of The Future Fund launched the One Global ETF FFND in August 2021, he snapped up Tesla, which quickly became the biggest position. By the second quarter of 2022, he began to trim as Musk started cutting electric-vehicle prices. Why Goldman Sachs says high-flying tech stocks may be headed for a tough stretch 'It might be another Apple or Microsoft': My wife invested $100K in one stock and it exploded 1,500%. Do we sell? U.S. debt-limit deadlock is making this favorite asset more scarce My friend, 83, wants to add me to his bank account to pay his bills. What could go wrong? One of our children has legal knowledge and lives far away, the other lacks financial savvy but lives nearby. Who should we appoint as executor? 'We didn't think that was a smart move. It turned out not to be a smart move, because they didn't get any incremental volume,' Black told MarketWatch in an interview on Monday. His Tesla haircuts continued, peppered by such worries as 'hype around unsupervised autonomy,' and when he finally exited it completely at $358 per share, valuation had gotten 'excessive.' Tesla shares need to be priced 'a lot less than they are today' for Black to repurchase. 'I don't want to call this stock uninvestable because at some price we would buy it back again, but with that level of volatility it almost makes the stock uninvestable at times,' he said, adding that Musk needs to 'keep his mouth closed and focus on the business.' Black, whose nearly 30-year career includes stints as CEO of Aegon Asset Management and Janus Capital, and his firm look after about $72 million in One Global, and the Long/Short ETF FFLS, roughly $49 million. One Global has returned 6.5% this year and 15% over three years, annualized, according to Morningstar, versus its MSCI All Country World Index benchmark returns of 7.3% and 14.3%, respectively. Black is now focused on what he sees as big tech bargains, such as Nvidia NVDA. The company's stock-picking process begins with 'ten long-term circular mega trends,' such as e-commerce, 24/7 information technology and, of course, artificial intelligence. 'We like the AI road map in front of [Nvidia] and they still can't make enough of their high-end AI chips. They continue to have extremely high demand for it, and they're still capacity constrained,' he said. Tesla, even with its recent decline, is still trading at 150 times forward earnings, while Nvidia sits at around 32 times, but is growing earnings, Black said. 'If you look at price-to-earnings relative to growth, which is how we think about the world, in a simplistic way, it's still reasonably cheap.' Meta META is also a big position. 'We like the growth we're seeing in Instagram and Facebook and WhatsApp. Again, the stock has done well, but it's still a very cheap stock,' trading at about 27 times earnings, he said. Then there's AMZN, and its vastly expanded offerings. 'You can buy prescription drugs over it now. You can buy tires, you can buy cars. It's become the go-to place if you want to buy anything,' and at around 35 times forward earnings, is now far less expensive, he said. He also flags DoorDash DASH. 'People don't have the time to make their own food anymore, so they order from the restaurants they love and [DoorDash] has gotten more and more restaurants on the platform, and as a result of that, the stock has done extremely well,' he said. Like Nvidia, DoorDash is reasonably priced, trading at 54 times forward earning, he said. His short bets in the Long/Short ETF, are about either poorly positioned companies or companies facing disruption. Those include Booking Holdings BKNG, which is in a 'very competitive business,' he said. 'We don't really see the proprietary technology to allow that to continue to gain share, so we decided that was a good short.' Fintech group Sofi Technologies SOFI is another. 'They've expanded their loans. and we just worry that they've grown too fast. and that's why it's a decent short we believe.' As the S&P 500 SPX continues to push past 6,000, Black says he's still bullish on the market overall, with expectations the Fed will likely to start cutting interest rates, though not as fast as Trump would like. 'I think what has happened because of the tariffs, the odds are you are going to have a first rate cut by September now,' he said. What else worries Black? He points to concerning 'pockets' of the market currently, such as the blockbuster Circle CRCL IPO, of which they didn't take part. 'We have stocks that are trading at very high multiples that aren't related to their earnings growth. We're always wary, especially in the growth space, that you've got speculative excess, and I think there are areas where people are just getting overly exuberant about prospects. And that's always negative,' said Black. Read: 'Big Money' turns bullish on stocks. Will that lead the S&P 500 to a 'melt up'? U.S. stocks SPX DJIA COMP are inching higher, while Treasury yields BX:TMUBMUSD10Y BX:TMUBMUSD02Y drop. Key asset performance Last 5d 1m YTD 1y S&P 500 6005.88 1.18% 2.77% 2.11% 12.03% Nasdaq Composite 19,591.24 1.81% 4.72% 1.45% 13.95% 10-year Treasury 4.456 -1.40 -1.70 -12.00 5.10 Gold 3349.9 -0.80% 2.93% 26.92% 43.53% Oil 65.56 3.50% 3.03% -8.78% -16.14% Data: MarketWatch. Treasury yields change expressed in basis points Need to Know starts early and is updated until the opening bell, but to get it delivered once to your email box. The emailed version will be sent out at about 7:30 a.m. Eastern. Trade talks between the U.S. and China continue in London on Tuesday. Tesla shares TSLA are tracking Monday's gains after more signs of a cooling feud between Musk and President Trump. J.M. Smucker stock SJM is down 7% after mixed results and a weak profit forecast from the food maker. Uber UBER said it's going to pilot self-driving cars in London. Tencent Music TME is reportedly buying China audio platform Ximalaya for $1.26 billion. The shares are rising. GameStop GME reports results after the close, and this analyst isn't that upbeat. A small-business optimism index was slightly more upbeat for May, with those expecting better business conditions at a historical high. Gold and the S&P 500 are chasing record highs at the same time. Here's why that's so rare. The White House marching orders that sparked the L.A. migrant crackdown. Mark Zuckerberg is handpicking a new 'superintelligence' AI team. Here's more evidence institutional investors are buying stocks again. This State Street risk-appetite index, based on the firm's $44 trillion of assets under custody and administration, shows 'long-term investor allocations to equities rose anew in May to levels last seen on the cusp of the Liberation Day announcement in early April,' said Dwyfor Evans, strategist at State Street Global Markets. While flows to stocks rose, investors continued to shun the dollar and U.S. Treasurys, Evans said. These were the most searched tickers on MarketWatch as of 6 a.m. Ticker Security name TSLA Tesla NVDA Nvidia GME GameStop PLTR Palantir Technologies PLUG Plug Power AAPL Apple TSM Taiwan Semiconductor Manufacturing AMD Advanced Micro Devices KLTO Klotho Neurosciences AMZN Amazon No joke. Comedian on why planes crash. Who you gonna call? Frustrated couple 'steal back' their own Jaguar. 'The situation is extreme': I'm 65 and leaving my estate to only one grandchild. Can the others contest my will? 'I prepaid our mom's rent for a year': My sister is a millionaire and never helps our mother. How do I cut her out of her will? I bought my mother-in-law a condo — and she took out a $30,000 car loan. Now she refuses to get a roommate. How do I make sure my son-in-law doesn't get his hands on my daughter's inheritance? My life partner is 18 years my senior. He wants to leave his $4.5 million fortune to me — not his two kids. Do we tell them? Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data